Oculis Holding AG (OISE:OCS)
kr 1,370 +20 (+1.48%) Market Cap: 86.72 Bil Enterprise Value: 52.41 Bil PE Ratio: 0 PB Ratio: 2.76 GF Score: 26/100

Oculis Holding AG at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 09:30 PM GMT
Release Date Price: kr2890 (-0.34%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OCS.OQ - Oculis Holding AG
Oculis Holding AG at JPMorgan Healthcare Conference
Jan 14, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome. Welcome everyone to the forty-fourth annual JPMorgan Healthcare Conference. My name is Tess Romero and I'm one of the senior biotech analysts here at JP Morgan. Our next presenting company is Oculus, and presenting on behalf of the company, we have CEO Riad Sharif. Riyad, over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Tessa. Very happy to be here and very pleased to introduce Oculus to you.

Thank you, ETSA and JPM for a great meeting and conference.

So we are a public company. NASDAQ listed here our Safe Harbor statement.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot